Atlantic International Corp.
NASDAQ:ATLNMedical - Diagnostics & Research
-$0.10 today
- Market cap
- $73.17M
- Beta
- 0.71
- P/E (TTM)
- -0.6
- EPS (TTM)
- -$1.08
Volume 18.56M
Average 0.44M
ATLN Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Atlantic International Corp.NASDAQ: ATLN
Selling, General & Admin · Q4 FY2025 · quarter ended Dec 2025
Selling, general & admin growth accelerates
Q4 FY2025 selling, general & admin of $33.13M rose 84.3% year over year, ahead of the +42.6% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 66.6% from the prior quarter. Over 3 fiscal years it compounded at +29.3% a year.
Context
- Selling, general & admin amounted to 20.9% of revenue in FY2025, up 6.5 pp from a year earlier.
- Selling, general & admin increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether selling, general & admin reaches the consensus estimate from 1 analysts of $63.72M (-30.2%) for the fiscal year ending Dec 2026, a slowdown from the +42.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterDec 2025
- $33.13M+66.6% QoQ
- Last fiscal yearDec 2025
- $91.29M+42.6% YoY
- LTMDec 2025
- $91.29M+42.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +84.3% | -24.2% | -108.5 pp |
| 1 year | +42.6% | -30.2% | -72.8 pp |
| 3-year CAGR | +29.3% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 91.29M USD
- Year-over-year change
- +42.6%
- 4-year CAGR
- +21.3%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 91.29M | +42.6% |
| FY2024 | 2024-12-31 | 64.02M | +40.9% |
| FY2023 | 2023-12-31 | 45.44M | +7.5% |
| FY2022 | 2022-12-31 | 42.27M | +0.2% |
| FY2021 | 2021-12-31 | 42.18M | — |
Selling, General & Admin vs competitors
How ATLN compares with its peers on the latest reported figures
- ATLN's LTM Dec 2025 selling, general & admin of $91.29M is the 3rd highest of the 8 companies compared; the peer median is $25.06M.
- Its year-over-year change of +42.6% is the 3rd highest of 8, against a peer median of +14.8%.
- Selling, general & admin amounts to 20.9% of revenue for ATLN, versus a peer median of 850.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $95.81M | +14.8% | +8.8% | 63.2% | |
| LTM Mar 2026 | $95.47M | +58.4% | +7.6% | 83.9% | |
ATLNAtlantic International Corp. | LTM Dec 2025 | $91.29M | +42.6% | +29.3% | 20.9% |
| LTM Mar 2026 | $34.83M | -4.4% | -11.4% | 1952.5% | |
| LTM Mar 2026 | $25.06M | -19.7% | +4.0% | — | |
| LTM Mar 2026 | $22.56M | +1.9% | +16.6% | — | |
IMDXInsight Molecular Diagnostics Inc. | LTM Mar 2026 | $17.81M | +22.1% | -7.6% | 914.0% |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $15.75M | +155.8% | +17.1% | 850.8% |
| Peer median (excluding ATLN) | $25.06M | +14.8% | +7.6% | 850.8% | |
Competitors are the stored peer set for ATLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 425.03M | 441.54M | 401.37M | 442.61M | 435.88M |
| Cost of Revenue | 370.62M | 387.34M | 354.5M | 395.43M | 389.89M |
| Gross Profit | 54.41M | 54.21M | 46.88M | 47.18M | 45.99M |
| Gross Margin | 12.8% | 12.3% | 11.7% | 10.7% | 10.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 42.18M | 42.27M | 45.44M | 64.02M | 91.29M |
| Operating Expenses | 90.14M | 48.23M | 50.33M | 69.01M | 96.22M |
| Depreciation & Amortization | 4.11M | 5.07M | 5.04M | 4.99M | 6.59M |
| EBITDA | 12.18M | 11.94M | 1.44M | (113.1M) | (43.64M) |
| EBITDA Margin | 2.9% | 2.7% | 0.4% | -25.6% | -10.0% |
| Operating Income | (35.73M) | 5.98M | (3.45M) | (21.83M) | (50.23M) |
| Operating Margin | -8.4% | 1.4% | -0.9% | -4.9% | -11.5% |
| Interest Income | 36.46K | 44.88K | 0 | 0 | 0 |
| Interest Expense | 208.29K | 90.75K | 17.54M | 12M | 9.16M |
| Other Income / Expenses | (3.73M) | (8.39M) | (17.73M) | (108.27M) | (9.16M) |
| Income Before Tax | (39.46M) | (2.41M) | (21.18M) | (130.1M) | (59.4M) |
| Pre-Tax Margin | -9.3% | -0.5% | -5.3% | -29.4% | -13.6% |
| Income Tax Expense | 1.33M | 808.43K | (5.93M) | 5.38M | 33.99K |
| Net Income | (40.8M) | (3.22M) | (15.25M) | (135.48M) | (59.43M) |
| Net Margin | -9.6% | -0.7% | -3.8% | -30.6% | -13.6% |
| EPS (Basic) | (0.17) | (0.19) | (0.60) | (3.68) | (1.08) |
| EPS (Diluted) | (0.17) | (0.17) | (0.60) | (3.68) | (1.08) |
| Weighted Avg Shares | 21.69M | 21.69M | 25.42M | 36.78M | 54.85M |
| Weighted Avg Shares (Diluted) | 21.69M | 24.14M | 25.42M | 36.78M | 54.85M |
Atlantic International Corp.
NASDAQ:ATLN
Intrinsic Alpha fair value
Locked
Current Price
$0.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.